The QATS Network Group supports translational research, with a focus on high levels of quality and regulatory compliance.
The ECMC QATS Network Group supports and enables ECMCs to conduct translational research to the appropriate levels of quality and regulatory compliance, utilising validated, cutting-edge techniques.
Bill Greenhalf, Liverpool (Chair)Bride Foster, CambridgeDebora Joseph-Pietras, SouthamptonFiona Kelly, Centre for Drug Development, Cancer Research UKKate Rolfvondenbaumen, SouthamptonSarah Smalley, Centre for Drug Development, Cancer Research UKKaren Swales, ICRFiona Thomson, Glasgow
The purpose of the Quality Assurance (QA) areas of expertise document is to make those working in QA within the ECMC Network aware of others working in the same area and to give you an idea of who you can contact with certain queries.
ECMC Network: QA areas of expertise (pdf)
Please note that by appearing in this listing, people are not claiming to be experts in any given area and you are not obliged to follow any advice that you receive.
If you would like to be included in this listing, please email email@example.com
The Experimental Cancer Medicine Centre initiative is jointly funded by Cancer Research UK, the National Institute for Health Research in England and the Departments of Health for Scotland, Wales and Northern Ireland.